Has acetylcysteine use changed the incidence of contrast nephropathy in hospitalized patients? A before-after study

American Journal of Medicine

Volumn 117, Issue 12, 2004, Pages 948-952

  Shah, Sanjiv J ^a,b   Hsu, Chi Yuan ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; CONTRAST MEDIUM;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG SCREENING; DRUG USE; FEMALE; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; INCIDENCE; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; METHODOLOGY; PRIORITY JOURNAL;

ACETYLCYSTEINE; AGED; AGED, 80 AND OVER; CONFOUNDING FACTORS (EPIDEMIOLOGY); CONTRAST MEDIA; FEMALE; HOSPITALIZATION; HUMANS; INCIDENCE; KIDNEY DISEASES; MALE; MIDDLE AGED;

EID: 11344285446     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjmed.2004.09.004     Document Type: Article

References (19)

1. S.W. Murphy, B.J. Barrett, P.S. Parfrey Contrast nephropathy J Am Soc Nephrol 11 2000 177 182
2. K. Nash, A. Hafeez, S. Hou Hospital-acquired renal insufficiency Am J Kidney Dis 39 2002 930 936
3. M. Tepel, M. van der Giet, C. Schwarzfeld, U. Laufer, D. Liermann, W. Zidek Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine N Engl J Med 343 2000 180 184
4. J. Kay, W.H. Chow, T.M. Chan Acetylcysteine for prevention of acute deterioration of renal function following elective coronary angiography and intervention a randomized controlled trial JAMA 289 2003 553 558
5. K.G. Shyu, J.J. Cheng, P. Kuan Acetylcysteine protects against acute renal damage in patients with abnormal renal function undergoing a coronary procedure J Am Coll Cardiol 40 2002 1383 1388
6. J.D. Durham, C. Caputo, J. Dokko A randomized controlled trial of N-acetylcysteine to prevent contrast nephropathy in cardiac angiography Kidney Int 62 2002 2202 2207
7. L.J. Diaz-Sandoval, B.D. Kosowsky, D.W. Losordo Acetylcysteine to prevent angiography-related renal tissue injury (the APART Trial) Am J Cardiol 89 2002 356 358
8. C. Briguori, F. Manganelli, P. Scarpato Acetylcysteine and contrast agent-associated nephrotoxicity J Am Coll Cardiol 40 2002 298 303
9. S. Allaqaband, R. Tumuluri, A.M. Malik Prospective randomized study of N-acetylcysteine, fenoldopam, and saline for prevention of radiocontrast-induced nephropathy Catheter Cardiovasc Interv 57 2002 279 283
10. R. Birck, S. Krzossok, F. Markowetz, P. Schnulle, F.J. van der Woude, C. Braun Acetylcysteine for prevention of contrast nephropathy meta-analysis Lancet 362 2003 598 603
11. A. Alonso, J. Lau, B.L. Jaber Prevention of radiocontrast nephropathy with N-acetylcysteine in patients with chronic kidney disease a meta-analysis of randomized, controlled trials Am J Kidney Dis 43 2004 1 9
12. D.W. Isenbarger, S.M. Kent, P.G. O'Malley Meta-analysis of randomized clinical trials on the usefulness of acetylcysteine for prevention of contrast nephropathy Am J Cardiol 92 2003 1454 1458
13. A.V. Kshirsagar, C. Poole, A. Mottl N-acetylcysteine for the prevention of radiocontrast induced nephropathy a meta-analysis of prospective controlled trials J Am Soc Nephrol 15 2004 761 769
14. P.D. Walker, K.L. Brokering, J.C. Theobald Fenoldopam and N-acetylcysteine for the prevention of radiographic contrast material-induced nephropathy a review Pharmacotherapy 23 2003 1617 1626
15. B.K. Nallamothu, K.G. Shojania, S. Saint Is acetylcysteine effective in preventing contrast-related nephropathy? A meta-analysis Am J Med 117 2004 938 947
16. D.F. Brophy Role of N-acetylcysteine in the prevention of radiocontrast-induced nephropathy Ann Pharmacother 36 2002 1466 1470
17. M. Tepel, W. Zidek Acetylcysteine and contrast media nephropathy Curr Opin Nephrol Hypertens 11 2002 503 506
18. A primer on before-after studies evaluating a report of a "successful" intervention Eff Clin Pract 5 2002 100 101
19. G.C. Curhan Prevention of contrast nephropathy JAMA 289 2003 606 608